Lumentum Holdings initiates coverage with outperform rating; price target $1,220
LITE•Bernstein initiated coverage of Lumentum Holdings with an outperform rating and a $1,220 price target.
Related News
Tandem Diabetes Care: Citigroup cuts target price to $20 from $24
TNDM•
H.C. Wainwright cuts Dyne Therapeutics target price to $32 from $50
DYN•
Clough Global Dividend and Income Fund pays monthly distribution of $0.0566 a share
GLV•
Honeywell to help build Dangote's new Kenyan mega-refinery
HON•
Tiziana Life Sciences submits request to FDA for orphan drug designation for intranasal foralumab for MSA
TLSA•